Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

RASSF1B Inhibitors

RASSF1B inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RASSF1B, one of the alternatively spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. RASSF1 plays an important role in cellular regulation by participating in processes such as apoptosis, cell cycle control, and cytoskeletal organization. Each isoform of the RASSF1 gene, including RASSF1B, performs distinct functions in these regulatory pathways. RASSF1B, in particular, is involved in modulating cellular responses to external signals that influence cell growth, survival, and differentiation. The protein interacts with Ras GTPases and other key signaling molecules to exert its regulatory effects. Inhibitors of RASSF1B work by binding to specific functional domains of the protein, disrupting its ability to interact with other proteins and signaling complexes, thereby impeding its role in regulating cellular processes.

The inhibition of RASSF1B has a direct impact on the signaling pathways in which it is involved, particularly those related to cell cycle regulation and apoptosis. By blocking the ability of RASSF1B to form critical protein-protein interactions, these inhibitors interfere with the control mechanisms that manage cellular growth, division, and programmed cell death. Researchers utilize RASSF1B inhibitors to explore the unique role of this isoform in comparison to other RASSF1 isoforms, such as RASSF1A, to understand the diversity of functions performed by each variant. This investigation also helps clarify how alternative splicing of the RASSF1 gene results in proteins that contribute to different cellular outcomes. The study of RASSF1B inhibitors also provides insights into the broader Ras signaling pathways, helping scientists understand how specific isoforms contribute to cellular homeostasis and the maintenance of a delicate balance between growth and apoptosis. Through these inhibitors, researchers gain a deeper understanding of the molecular mechanisms underlying cellular regulation and the impact of protein interactions on essential cellular functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could downregulate RASSF1B expression by causing DNA demethylation at the gene's promoter, thereby decreasing transcription initiation.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine may lower RASSF1B levels by specifically targeting DNA methyltransferases for inhibition, leading to promoter demethylation and transcriptional repression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid could decrease RASSF1B expression by altering histone acetylation patterns, resulting in a condensed chromatin state less conducive to gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

This compound might reduce RASSF1B gene transcription by inhibiting histone deacetylase activity, leading to chromatin remodeling that silences gene expression.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$214.00
$622.00
1
(1)

Romidepsin has the potential to inhibit RASSF1B expression by changing histone acetylation levels, which could suppress gene transcription.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

MS-275 may repress RASSF1B transcription by inhibiting histone deacetylase enzymes, resulting in compact chromatin that is transcriptionally inactive.

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

This compound could inhibit RASSF1B expression by acting as a histone deacetylase inhibitor, which would alter the chromatin landscape around the gene locus.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Methotrexate could indirectly decrease RASSF1B expression by disrupting folate metabolism, which is crucial for the generation of methyl groups used in DNA methylation.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Disulfiram may indirectly inhibit RASSF1B expression by inhibiting aldehyde dehydrogenase, which might influence acetylation and the subsequent gene expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A could bind DNA in the promoter region of RASSF1B, inhibiting the binding of transcriptional machinery and thus downregulating the gene's expression.